TL
Tom Y Lee
Director10% Owner

Tom Y Lee insider trades: Pure Bioscience (PURE) stock buys and sales

Director, Pure Bioscience Last trade Dec 15, 2022 28 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2016
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Tom reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 15, 2022PURE↑ Buy$7K
Mar 21, 2022PURE↑ Buy$43K
Jun 16, 2021PURE↑ Buy$16K
Dec 24, 2020PURE↑ Buy$52K
Jun 22, 2020PURE↑ Buy$94K
Jun 17, 2020PURE↑ Buy$352K
Dec 19, 2019PURE↑ Buy$218K
Oct 2, 2019PURE↑ Buy$290K
Aug 16, 2018PURE↑ Buy$1.1M
Dec 21, 2016PURE↓ Sell$14K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Tom Y Lee's insider trades

Tom Y Lee is a director at Pure Bioscience (PURE). Since Dec 21, 2016, Tom has reported 9 open-market purchases worth $2.1M and 1 sale worth $14K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (17 filings), option exercises (3 filings), other transactions (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PURE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.